PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 3.64 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $1,327,000 | -52.3% | 101,966 | -49.0% | 0.12% | -63.5% |
| Q2 2016 | $2,782,000 | +104.9% | 200,000 | +123.4% | 0.34% | +82.2% |
| Q1 2016 | $1,358,000 | -49.4% | 89,531 | -36.7% | 0.18% | -28.8% |
| Q4 2015 | $2,682,000 | +4.0% | 141,367 | +4.2% | 0.26% | +15.6% |
| Q3 2015 | $2,578,000 | -28.5% | 135,710 | -3.1% | 0.22% | -12.1% |
| Q2 2015 | $3,607,000 | – | 140,000 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AIGH Capital Management LLC | 1,609,398 | $7,821,000 | 1.64% |
| Telemetry Investments, L.L.C. | 242,514 | $1,179,000 | 1.59% |
| Omega Fund Management, LLC | 2,606,809 | $12,669,000 | 1.42% |
| Bruce & Co., Inc. | 1,343,312 | $6,528,000 | 1.39% |
| 1492 Capital Management LLC | 488,309 | $2,373,000 | 1.20% |
| Abingworth LLP | 1,041,131 | $5,060,000 | 1.15% |
| Trellus Management Company, LLC | 295,000 | $1,434,000 | 1.04% |
| Worth Venture Partners, LLC | 389,440 | $1,893,000 | 0.85% |
| CM Management, LLC | 200,000 | $972,000 | 0.72% |
| GENERAL AMERICAN INVESTORS CO INC | 1,112,658 | $5,408,000 | 0.46% |